Navigation Links
New Applications for Cognitive Training
Date:11/21/2008

tists from prestigious universities to design and test its computer-based programs. More than 30 published papers show that in randomized controlled trials the company's patented technologies significantly increase processing speed, improve memory and attention, and enhance the quality of everyday life. Posit Science has received grants from the National Institutes of Health and has received numerous awards and accolades. The company's products, scientists and science are currently featured in the PBS documentaries "The Brain Fitness Program" and "Brain Fitness 2: Sight and Sound." For more information, visit http://www.PositScience.com or call 1-800-599-6463.


'/>"/>
SOURCE Posit Science
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Mindray Selects Actel Low-Power Flash FPGAs for Demanding Medical Equipment Applications
2. Novel semiconductor structure bends light wrong way -- the right direction for many applications
3. Innocoll Receives Intends to Grant Notices from the European Patent Office for Two European Patent Applications Related to Novel Wound Healing, Biosurgery and Drug Delivery Applications of its CollaRx(R) Technology
4. NanoLogix Inc. Files Multiple International Patent Applications for BioNanoChannel(TM) and Hydrogen Bioreactor Technology
5. ECO2 Plastics to File for FDA Approval for Food-Contact Applications
6. Medarex to Receive Milestone Payment for Submission of Regulatory Applications Requesting Approval of Ustekinumab (CNTO 1275) for Treatment of Psoriasis
7. Stem Cell Institute Correct in Rejecting Applications Over Conflicts of Interest; Institutions, Board Members Involved Must Be Identified, Consumer Advocates Say
8. CSC Signs Extension to Managed Applications Services Agreement With Sun Microsystems
9. UIC College of Nursing in Peoria Now Accepting Applications for New Doctorate of Nursing Practice
10. EaglePicher Technologies Introduces First Implantable Medical Cell Designed Specifically for Monitoring Applications
11. New nanotube findings by Stanford researchers give boost to potential biomedical applications
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/8/2009)... Md., Jan. 8 Hanger Ort...nnounce that throughout the fourth quarter of 2008...Center, Rocky Mountain Orthotic-Prosthetics Center...c., First Coast Orthotics & Prosthetics, and O...isitions add patient care centers to existing mark...
(Date:1/8/2009)...ounced Acquisition in 2009 Continues Growth Trend ...-FirstCall/ -- IPC The Hospitalist Company, Inc. (...hysician group practice company, announced today t...dwest Acute Care Consultants, Inc. (MACC) in St. L...ed expansion in the St. Louis market, where IPC ha...
(Date:1/8/2009)...SDA, Md., Jan. 8 /PRNewswire-Asia/ -- Chindex Inte... Company"), a leading independent American,provid...the People,s Republic,of China, today announced t...China Conference, to be held in Shanghai on Januar...na Conference will be held at the Pudong Shangri-,...
(Date:1/8/2009)..., Md., Jan. 8 A new edu...ce and guidance on drugs, biological products and ...earch and Quality,s Centers for Education and Rese...d network of more than a dozen leading research ce...dvisory Information Network ( CHAIN ) http://www....
Breaking Medicine News(10 mins):Health News:Hanger Orthopedic Group, Inc. Announces Six Acquisitions Totaling $8.9 Million of Annual Net Revenue 2Health News:IPC The Hospitalist Company Acquires Missouri Practice Group 2Health News:Chindex International Inc. Announces Participation in the 2009 UBS Greater China Conference 2Health News:AHRQ Announces New Web Site on Emerging Issues in Medical Therapeutics 2
...fully engineered adult stem cells from human umbil...elp cure type 1 diabetes by allowing people to gro...or defective pancreas. The study was conducted by...led by Dr. Randall J. Urban at University of Texas...
...y researchers at Mayo Clinic College of Medicine i...lp their patients stop smoking by referring them ...chers randomly assigned eight general dental pract...nseling regarding smoking cessation, or brief coun...
...anthrax in Orissa's tribal dominated Koraput distr... in the last two days, health officials said Frid...ni, 35, of Padiguda village under Semliguda block ...rom Bhubaneswar, fell to the disease reportedly af...
...Saturday confirmed a case of H5N1 infection known ...ry identified the man by his surname, Cheng, and s...n Army hospital. But it did not specify his unit... came from, maintaining the government's customary...
Other Medicine News:
(Date:1/6/2009)...an. 6 Pacira Pharmaceuticals, Inc.... announced today that enrollment,has been complet...ate the,safety and efficacy of a single intraoper...ine) for prolonged postoperative analgesia. , ...d in total knee,arthroplasty (TKA) are expected t...
(Date:1/5/2009)... 5 Micromet, Inc.,(Nasd...ng novel, proprietary,antibodies for the treatmen...,provides an outlook on key events anticipated fo...ovide an update on its research and development,p... 12 to 16, 2009: Update on several preclinical BiT...
(Date:12/30/2008)...Newswire-USNewswire/ -- The Coalition for 21st Cen...n filed by Genentech, Inc. on December 5, 2008, se...ffer diagnostic tests to physicians and patients. ...sts, would harm patient care and rests on flawed s...,s mission is to encourage the research, developme...
(Date:12/27/2008)...Dec. 27 According to the latest,s... consume modest doses of,resveratrol plus an arra...n 3,to 5 glasses of aged, red wine, rather than r...wscom.com/cgi-bin/prnh/20080603/LATU039 ) , ...l alone fails to prolong,the life of laboratory m...
Breaking Medicine Technology:Phase III Studies of EXPAREL(TM) (DepoBupivacaine) from Pacira Complete Enrollment 2Phase III Studies of EXPAREL(TM) (DepoBupivacaine) from Pacira Complete Enrollment 3Micromet Key Events for 2009 2Micromet Key Events for 2009 3Micromet Key Events for 2009 4Micromet Key Events for 2009 5Coalition for 21st Century Medicine Issues Statement in Opposition of Genentech Petition to Restrict Lab Use of Diagnostic Tests for Physicians and Patients 2Coalition for 21st Century Medicine Issues Statement in Opposition of Genentech Petition to Restrict Lab Use of Diagnostic Tests for Physicians and Patients 3Coalition for 21st Century Medicine Issues Statement in Opposition of Genentech Petition to Restrict Lab Use of Diagnostic Tests for Physicians and Patients 4Longevity Seekers Advised to Consume Modest Doses of Red Wine Molecules in Dietary Supplements (Longevinex(R)) Rather than Mega-Dose Resveratrol Alone 2Longevity Seekers Advised to Consume Modest Doses of Red Wine Molecules in Dietary Supplements (Longevinex(R)) Rather than Mega-Dose Resveratrol Alone 3Nurse Practitioner Fights Back as 113 Million U S Households Face Risk of Contamination 32287 1Nurse Practitioner Fights Back as 113 Million U S Households Face Risk of Contamination 32287 2City of Newark Ohio Increases Safety Services with EMS Revenue Recovered by MED3OOO EMS Billing 32285 1City of Newark Ohio Increases Safety Services with EMS Revenue Recovered by MED3OOO EMS Billing 32285 2City of Newark Ohio Increases Safety Services with EMS Revenue Recovered by MED3OOO EMS Billing 32285 3Quitting Smoking Can Be a Parents Best New Years Resolution 32284 1Quitting Smoking Can Be a Parents Best New Years Resolution 32284 2Quitting Smoking Can Be a Parents Best New Years Resolution 32284 3Quitting Smoking Can Be a Parents Best New Years Resolution 32284 4CeloNova BioSciences Receives FDA Market Approval for Embozene 28TM 29 Color Advanced Microspheres Embolization Platform 32282 1CeloNova BioSciences Receives FDA Market Approval for Embozene 28TM 29 Color Advanced Microspheres Embolization Platform 32282 2CeloNova BioSciences Receives FDA Market Approval for Embozene 28TM 29 Color Advanced Microspheres Embolization Platform 32282 3CeloNova BioSciences Receives FDA Market Approval for Embozene 28TM 29 Color Advanced Microspheres Embolization Platform 32282 4
...ms and Urine Flow, With,Long Lasting Effect in Pha...re-FirstCall/ -- Spectrum,Pharmaceuticals, Inc., t...r ozarelix, the Company,s drug candidate for the t... the American Urology,Association Annual Meeting h...alifornia on Tuesday, May 22, 2007. , "The results...
...ncer Studies; 9 Targeted,Agent Studies, INDIANAPOL...ncology will unveil 76 studies at the 43rd Annual ...gy (ASCO) in Chicago, Ill. from,June 1-5, 2007. Th... (gemcitabine HCl for injection), ALIMTA(R) (pemet...ational, oral, targeted,therapy. There will also b...
Other Medicine Technology:Ozarelix Phase 2 Data in Benign Prostatic Hypertrophy Presented at,Annual Meeting of American Urological Association 2Ozarelix Phase 2 Data in Benign Prostatic Hypertrophy Presented at,Annual Meeting of American Urological Association 3Ozarelix Phase 2 Data in Benign Prostatic Hypertrophy Presented at,Annual Meeting of American Urological Association 4Ozarelix Phase 2 Data in Benign Prostatic Hypertrophy Presented at,Annual Meeting of American Urological Association 5Making Science Personal: Lilly Oncology to Unveil 76 Studies at,ASCO 2007 2
...laboratory and a worldwide leader in innovative la...extensive test menu of highly complex and unique m...wned by the University of Utah, ARUP Laboratories'...iversity teaching hospitals and children's hospita...
...laboratory and a worldwide leader in innovative la...extensive test menu of highly complex and unique m...wned by the University of Utah, ARUP Laboratories'...iversity teaching hospitals and children's hospita...
...laboratory and a worldwide leader in innovative la...extensive test menu of highly complex and unique m...wned by the University of Utah, ARUP Laboratories'...iversity teaching hospitals and children's hospita...
...laboratory and a worldwide leader in innovative la...extensive test menu of highly complex and unique m...wned by the University of Utah, ARUP Laboratories'...iversity teaching hospitals and children's hospita...
Medicine Products: